Evidence map›Paper›PMID 30459127›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2019

Level of serum soluble Tim-3 expression in early-phase acute pancreatitis.

Min Lin, Jin Huang, Jian Huang, Sheng-Lan Liu, Wei-Chang Chen

Open access · bronzeAbstract readClinical Study
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Min LinDepartment of Gastroenterology, the Affiliated Changzhou No.2 People's Hospital with Nanjing Medical University, Changzhou, China.
Jin HuangDepartment of Gastroenterology, the Affiliated Changzhou No.2 People's Hospital with Nanjing Medical University, Changzhou, China.
Jian HuangDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Sheng-Lan LiuDepartment of ICU, the First Affiliated Hospital of Soochow University, Suzhou, China.
Wei-Chang ChenDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Soochow University · CNChangzhou No.2 People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsT-cell immunoglobulin and mucin domain 3 (Tim-3) assumedly play a crucial immunomodulatory role in inflammatory response. Data on the potential role of soluble Tim-3 (sTim-3) in acute pancreatitis (AP) are scarce. We conducted a prospective clinical study to characterize its role in the early-phase AP.

methodsIn total, 44 patients with AP (16 mild and 28 none-mild) who presented within 24 hours on admission and 20 healthy volunteers (NC) were included in our study. Serum interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α, and sTim-3 levels were detected using enzyme-linked immunosorbent assay (ELISA).

resultsLevels of the pro-inflammatory cytokines IL-6 and TNF-α and the anti-inflammatory cytokine IL-10 in the none-mild and mild groups were significantly elevated compared with those of the NC group. The sTim-3 levels of the none-mild and mild group were significantly increased compared with the NC. The sTim-3 level positively correlated with the IL-6 and TNF-α but showed no obvious correlations with the IL-10 level. The sTim-3 level positively correlated with the APACHE II score.

conclusionThe results indicate that sTim-3 participates in the early progression of AP by positively regulating the pro-inflammatory cytokines and that the measurement of serum sTim-3 is an early marker for predicting AP.

Indexed as

Acute DiseaseAdultAPACHEDisease ProgressionEnzyme-Linked Immunosorbent AssayFemaleHepatitis A Virus Cellular Receptor 2HumansInterleukin-10Interleukin-6MaleMiddle AgedPancreatitisProspective StudiesTumor Necrosis Factor-alphaHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2IL10 protein, humanInterleukin-10Interleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID30459127
PMCPMC6408170
OpenAlexW2900878045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.